Trial Profile
Clinical Trials Insight: 700026207
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 07 May 2009
Price :
$35
*
At a glance
- Drugs LErafAON (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors NeoPharm Inc
- 29 Apr 2009 NeoPharm is developing clinical protocols for Phase I and II studies of pancreatic cancer with LE-rafAON in combination with the drug gemcitabine, according to a company media release.
- 13 May 2008 IND submission expected mid-2008.
- 20 Aug 2007 New trial record.